McNeill RV, Kehrwald C, Brum M, Knopf K, Brunkhorst-Kanaan N, Etyemez S, Koreny C, Bittner R, Freudenberg F, Herterich S, Reif A, Kittel-Schneider S (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 101
Pages Range: 275-283
DOI: 10.1016/j.bbi.2022.01.006
Nitric oxide (NO) signalling has been implicated in the pathogenesis of several mental illnesses; however, its specific contribution remains unclear. We investigated whether peripheral NO concentration is associated with specific diagnoses, and whether there is a correlation with genetic variation in NO synthase (NOS) genes. We included 185 participants in the study; 52 healthy controls, 43 major depressive disorder (MDD) patients, 41 bipolar disorder (BPD) patients, and 49 schizophrenia (SCZ) patients. Clinical, genetic, and biochemical data were collected at admission to a psychiatric hospital and at discharge. Serum was used to quantify concentration of the stable NO metabolites nitrite and nitrate. Individuals were genotyped for the NOS1 exon 1f variable number of tandem repeats 1 (VNTR1) polymorphism, and single nucleotide polymorphisms (SNPs) in the NOS1, NOS1AP and NOS3 genes. At admission, SCZ patients were found to have significantly higher peripheral NO metabolite (NO
APA:
McNeill, R.V., Kehrwald, C., Brum, M., Knopf, K., Brunkhorst-Kanaan, N., Etyemez, S.,... Kittel-Schneider, S. (2022). Uncovering associations between mental illness diagnosis, nitric oxide synthase gene variation, and peripheral nitric oxide concentration. Brain Behavior and Immunity, 101, 275-283. https://doi.org/10.1016/j.bbi.2022.01.006
MLA:
McNeill, Rhiannon V., et al. "Uncovering associations between mental illness diagnosis, nitric oxide synthase gene variation, and peripheral nitric oxide concentration." Brain Behavior and Immunity 101 (2022): 275-283.
BibTeX: Download